Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff… - European journal of …, 2009 - Elsevier
PURPOSE: Evaluation of the influence of immunohistochemically defined breast cancer
(BC) subtypes and other risk factors on the development of cerebral metastases (CM) …
Save Cite Cited by 296 Related articles

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

F Heitz, P Harter, HJ Lueck… - European Journal of …, 2009 - europepmc.org
Purpose Evaluation of the influence of immunohistochemically defined breast cancer (BC)
subtypes and other risk factors on the development of cerebral metastases (CM). Methods …
Cite

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck… - … journal of cancer …, 2009 - pubmed.ncbi.nlm.nih.gov
Purpose Evaluation of the influence of immunohistochemically defined breast cancer (BC)
subtypes and other risk factors on the development of cerebral metastases (CM). Methods …
Cite

[CITATION][C] Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F HEITZ, P HARTER, HJ LUECK… - European journal of …, 2009 - pascal-francis.inist.fr
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an
earlier occurrence of cerebral metastases CNRS Inist Pascal-Francis CNRS Pascal and …
Cite

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff… - European Journal of …, 2009 - ejcancer.com
Purpose Evaluation of the influence of immunohistochemically defined breast cancer (BC)
subtypes and other risk factors on the development of cerebral metastases (CM). Methods …
Cite

[CITATION][C] Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff… - European Journal of …, 2009 - cir.nii.ac.jp
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an
earlier occurrence of cerebral metastases | CiNii Research CiNii 国立情報学研究所 学術情報 …
Cite

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff… - European Journal of …, 2009 - infona.pl
Evaluation of the influence of immunohistochemically defined breast cancer (BC) subtypes
and other risk factors on the development of cerebral metastases (CM). Exploratory analysis …
Cite

[CITATION][C] Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F HEITZ - Eur J Cancer, 2009 - cir.nii.ac.jp
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an
earlier occurrence of cerebral metastases | CiNii Research CiNii 国立情報学研究所 学術情報 …
Cite

[CITATION][C] Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases

F HEITZ, P HARTER, HJ LUECK… - European journal of …, 2009 - Elsevier
Cite